
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Diabetes & Obesity Series
Subscribe to RSS feed of this series
R. Paul Robertson, MD, President and Scientific Director Pacific Northwest Diabetes Research Institute President-Elect, Science and Medicine, American Diabetes Association
In this podcast he explores the genetic factors and health drivers behind the increase in type II diabetes.
Others in the Series
Articles, Multimedia
Associations and Societies
Clinical Trials
Articles, Multimedia
Associations and Societies
Clinical Trials






